venous thrombotic events.  Plasma exchange remains advisable in patients with GPA or MPA who also have anti-glomerular basement membrane disease. Recommendation: In patients with active, severe GPA/MPA with alveolar hemorrhage, we conditionally recommend against adding plasma exchange to remission induction therapies. Two trials evaluated the use of plasma exchange in patients presenting with alveolar hemorrhage, and no differences in mortality or remission rates were observed. Thus, plasma